- Home
- Publications
- Publication Search
- Publication Details
Title
Motif mediated protein-protein interactions as drug targets
Authors
Keywords
Protein-protein interactions, Linear motifs, Drug discovery, Small-molecule inhibitors, Peptidomimetics, Peptides as therapeutics
Journal
Cell Communication and Signaling
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-03-03
DOI
10.1186/s12964-016-0131-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An Amphipathic Undecapeptide with All d-Amino Acids Shows Promising Activity against Colistin-Resistant Strains of Acinetobacter baumannii and a Dual Mode of Action
- (2015) Alberto Oddo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Thermodynamics and Kinetics of Drug Binding. Edited by György M. Keseru and David C. Swinney
- (2015) Stefan Geschwindner ChemMedChem
- Peptide therapeutics: current status and future directions
- (2015) Keld Fosgerau et al. DRUG DISCOVERY TODAY
- Nanobiotechnology and its applications in drug delivery system: a review
- (2015) Imran Khan et al. IET Nanobiotechnology
- Drug Carrier for Photodynamic Cancer Therapy
- (2015) Tilahun Debele et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Applications of Magnetic Nanoparticles in Targeted Drug Delivery System
- (2015) Xianbo Mou et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Recent advances on d-amino acid research
- (2015) Kenji Hamase JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- ABT-199, a BH3 mimetic that specifically targets Bcl-2, enhances the antitumor activity of chemotherapy, bortezomib and JQ1 in “double hit” lymphoma cells
- (2015) Nadine Johnson-Farley et al. LEUKEMIA & LYMPHOMA
- Cell-Penetrating Peptides: Possibilities and Challenges for Drug Delivery in Vitro and in Vivo
- (2015) Tore Skotland et al. MOLECULES
- A modular toolkit to inhibit proline-rich motif–mediated protein–protein interactions
- (2015) Robert Opitz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Direct inhibition of oncogenic KRAS by hydrocarbon-stapled SOS1 helices
- (2015) Elizaveta S. Leshchiner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Delivery of mirror image polypeptides into cells
- (2015) Amy E. Rabideau et al. Chemical Science
- Advances and Challenges of Liposome Assisted Drug Delivery
- (2015) Lisa Sercombe et al. Frontiers in Pharmacology
- A d-Amino Acid at the N-Terminus of a Protein Abrogates Its Degradation by the N-End Rule Pathway
- (2015) Amy E. Rabideau et al. ACS Central Science
- Abstract 2610: AMG 232, a small molecular inhibitor of MDM2 augments radiation response in human tumors harboring wild-type p53
- (2015) Lauryn Werner et al. CANCER RESEARCH
- Delivery of Antibody Mimics into Mammalian Cells via Anthrax Toxin Protective Antigen
- (2014) Xiaoli Liao et al. CHEMBIOCHEM
- Peptides Come Round: Using SICLOPPS Libraries for Early Stage Drug Discovery
- (2014) Katherine R. Lennard et al. CHEMISTRY-A EUROPEAN JOURNAL
- PDZ Domain-mediated Protein Interactions: Therapeutic Targets in Neurological Disorders
- (2014) Z. Khan et al. CURRENT MEDICINAL CHEMISTRY
- Phase I Dose-Escalation Study of LCL161, an Oral Inhibitor of Apoptosis Proteins Inhibitor, in Patients With Advanced Solid Tumors
- (2014) Jeffrey R. Infante et al. JOURNAL OF CLINICAL ONCOLOGY
- Hydrocarbon-Stapled Peptides: Principles, Practice, and Progress
- (2014) Loren D. Walensky et al. JOURNAL OF MEDICINAL CHEMISTRY
- Proteome-wide analysis of human disease mutations in short linear motifs: neglected players in cancer?
- (2014) Bora Uyar et al. Molecular BioSystems
- Drug-Like ProteinProtein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology
- (2014) Bruno O. Villoutreix et al. Molecular Informatics
- Drugging the p53 pathway: understanding the route to clinical efficacy
- (2014) Kian Hoe Khoo et al. NATURE REVIEWS DRUG DISCOVERY
- Enzyme-Catalyzed Macrocyclization of Long Unprotected Peptides
- (2014) Chi Zhang et al. ORGANIC LETTERS
- Large-scale interaction profiling of PDZ domains through proteomic peptide-phage display using human and viral phage peptidomes
- (2014) Y. Ivarsson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hot spots in protein–protein interfaces: Towards drug discovery
- (2014) Engin Cukuroglu et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- FP tethering: a screening technique to rapidly identify compounds that disrupt protein–protein interactions
- (2014) Jean M. Lodge et al. MedChemComm
- Inhibitors of Difficult Protein–Protein Interactions Identified by High-Throughput Screening of Multiprotein Complexes
- (2013) Laura C. Cesa et al. ACS Chemical Biology
- ABT-199: Taking Dead Aim at BCL-2
- (2013) Matthew S. Davids et al. CANCER CELL
- Cell-penetrating peptides: 20 years later, where do we stand?
- (2013) Chérine Bechara et al. FEBS LETTERS
- Combination therapy of cilengitide with belotecan against experimental glioblastoma
- (2013) Young-Hoon Kim et al. INTERNATIONAL JOURNAL OF CANCER
- A Potent Small-Molecule Inhibitor of the MDM2–p53 Interaction (MI-888) Achieved Complete and Durable Tumor Regression in Mice
- (2013) Yujun Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ordering a Dynamic Protein Via a Small-Molecule Stabilizer
- (2013) Ningkun Wang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A Perfluoroaryl-Cysteine SNAr Chemistry Approach to Unprotected Peptide Stapling
- (2013) Alexander M. Spokoyny et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy
- (2013) Yong S. Chang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Deconstruction of a Nutlin: Dissecting the Binding Determinants of a Potent Protein–Protein Interaction Inhibitor
- (2013) David C. Fry et al. ACS Medicinal Chemistry Letters
- Combination treatment in vitro with Nutlin, a small-molecule antagonist of MDM2, and pegylated interferon- 2a specifically targets JAK2V617F-positive polycythemia vera cells
- (2012) M. Lu et al. BLOOD
- A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306)
- (2012) L. Burt Nabors et al. CANCER
- Dissecting Fragment-Based Lead Discovery at the von Hippel-Lindau Protein:Hypoxia Inducible Factor 1α Protein-Protein Interface
- (2012) Inge Van Molle et al. CHEMISTRY & BIOLOGY
- A novel combination therapy approach for the treatment of acute myeloid leukemia: the multi-kinase inhibitor sorafenib and the HDM2 inhibitor nutlin-3
- (2012) E. Weisberg et al. HAEMATOLOGICA
- Turning Receptors On and Off with Intracellular Pepducins: New Insights into G-protein-coupled Receptor Drug Development
- (2012) Katie O'Callaghan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- AM-8553: A Novel MDM2 Inhibitor with a Promising Outlook for Potential Clinical Development
- (2012) Denzil Bernard et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)
- (2012) John A. Flygare et al. JOURNAL OF MEDICINAL CHEMISTRY
- MDM4 is a key therapeutic target in cutaneous melanoma
- (2012) Agnieszka Gembarska et al. NATURE MEDICINE
- Interpreting protein networks with three-dimensional structures
- (2012) Joan Teyra et al. NATURE METHODS
- Strategies for membrane interaction proteomics: No mass spectrometry required
- (2012) Mandy H. Y. Lam et al. PROTEOMICS
- Exploiting the Cancer Genome: Strategies for the Discovery and Clinical Development of Targeted Molecular Therapeutics
- (2011) Timothy A. Yap et al. Annual Review of Pharmacology and Toxicology
- Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation
- (2011) Carlos Mas-Moruno et al. Anti-Cancer Agents in Medicinal Chemistry
- Phage display can select over-hydrophobic sequences that may impair prediction of natural domain–peptide interactions
- (2011) Katja Luck et al. BIOINFORMATICS
- Identification of specificity determining residues in peptide recognition domains using an information theoretic approach applied to large-scale binding maps
- (2011) Kevin Y Yip et al. BMC BIOLOGY
- A Class of Human Proteins that Deliver Functional Proteins into Mammalian Cells In Vitro and In Vivo
- (2011) James J. Cronican et al. CHEMISTRY & BIOLOGY
- Split-protein systems: beyond binary protein–protein interactions
- (2011) Sujan S Shekhawat et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- An omics perspective of protein disorder
- (2011) Jeremy Bellay et al. Molecular BioSystems
- An orthosteric inhibitor of the Ras-Sos interaction
- (2011) Anupam Patgiri et al. Nature Chemical Biology
- Expanding the horizon of chemotherapeutic targets: From MDM2 to MDMX (MDM4)
- (2011) Antonio Macchiarulo et al. MedChemComm
- A Stapled p53 Helix Overcomes HDMX-Mediated Suppression of p53
- (2010) Federico Bernal et al. CANCER CELL
- Residue-specific incorporation of non-canonical amino acids into proteins: recent developments and applications
- (2010) Jeremiah A Johnson et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Small-molecule pan-IAP antagonists: a patent review
- (2010) John A Flygare et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Targeting protein–protein interactions for therapeutic intervention: a challenge for the future
- (2010) Giovanna Zinzalla et al. Future Medicinal Chemistry
- The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer
- (2010) Michelle L Stewart et al. Nature Chemical Biology
- D-peptide inhibitors of the p53-MDM2 interaction for targeted molecular therapy of malignant neoplasms
- (2010) M. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- How viruses hijack cell regulation
- (2010) Norman E. Davey et al. TRENDS IN BIOCHEMICAL SCIENCES
- The p53 orchestra: Mdm2 and Mdmx set the tone
- (2010) Mark Wade et al. TRENDS IN CELL BIOLOGY
- Novel Peptide-Mediated Interactions Derived from High-Resolution 3-Dimensional Structures
- (2010) Amelie Stein et al. PLoS Computational Biology
- Targeting Mdm2 and Mdmx in Cancer Therapy: Better Living through Medicinal Chemistry?
- (2009) Mark Wade et al. MOLECULAR CANCER RESEARCH
- Protein promiscuity and its implications for biotechnology
- (2009) Irene Nobeli et al. NATURE BIOTECHNOLOGY
- N-Methylation of Peptides: A New Perspective in Medicinal Chemistry
- (2008) Jayanta Chatterjee et al. ACCOUNTS OF CHEMICAL RESEARCH
- Synthesis of Natural-Product-Like Molecules with Over Eighty Distinct Scaffolds
- (2008) Daniel Morton et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Structure-activity relationship and metabolic stability studies of backbone cyclization and N-methylation of melanocortin peptides
- (2008) Yaniv Linde et al. BIOPOLYMERS
- Principles of Protein−Protein Interactions: What are the Preferred Ways For Proteins To Interact?
- (2008) Ozlem Keskin et al. CHEMICAL REVIEWS
- Peptidomimetics, a synthetic tool of drug discovery
- (2008) Josef Vagner et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Small molecular weight protein–protein interaction antagonists—an insurmountable challenge?
- (2008) Alexander Dömling CURRENT OPINION IN CHEMICAL BIOLOGY
- Understanding eukaryotic linear motifs and their role in cell signaling and regulation
- (2008) Francesca Diella Frontiers in Bioscience-Landmark
- The BCL-2 protein family: opposing activities that mediate cell death
- (2007) Richard J. Youle et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started